Cargando…

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension

The renin-angiotensin-aldosterone system (RAAS) is a dominant player in several cardiovascular pathologies. This study investigated whether alterations induced by l-NAME, (NLG)-nitro-l-arginine methyl ester, a nitric oxide synthase inhibitor, and the protective effect of melatonin are associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simko, Fedor, Baka, Tomas, Krajcirovicova, Kristina, Repova, Kristina, Aziriova, Silvia, Zorad, Stefan, Poglitsch, Marko, Adamcova, Michaela, Reiter, Russel J., Paulis, Ludovit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017142/ https://www.ncbi.nlm.nih.gov/pubmed/29382124 http://dx.doi.org/10.3390/molecules23020265

Ejemplares similares

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
por: Simko, Fedor, et al.
Publicado: (2022)

Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury
por: Simko, Fedor, et al.
Publicado: (2020)

Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
por: Stanko, Peter, et al.
Publicado: (2020)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
por: Repova, Kristina, et al.
Publicado: (2022)

Melatonin as a Potential Approach to Anxiety Treatment
por: Repova, Kristina, et al.
Publicado: (2022)

Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin
por: Simko, Fedor, et al.
Publicado: (2014)

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
por: Simko, Fedor, et al.
Publicado: (2017)

Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
por: Simko, Fedor, et al.
Publicado: (2021)

Cardiovascular therapeutics: A new potential for anxiety treatment?
por: Repova, Kristina, et al.
Publicado: (2022)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
por: Adamcova, Michaela, et al.
Publicado: (2021)

Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches
por: Unger, Thomas, et al.
Publicado: (2011)

Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
por: Pechanova, Olga, et al.
Publicado: (2014)

Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology
por: Hrenak, Jaroslav, et al.
Publicado: (2016)

Activation of the Renin–Angiotensin–Aldosterone System Is Attenuated in Hypertensive Compared with Normotensive Pregnancy
por: Shoemaker, Robin, et al.
Publicado: (2023)

The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
por: Dörr, Katharina, et al.
Publicado: (2022)

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
por: Simko, Fedor, et al.
Publicado: (2020)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
por: Simko, Fedor, et al.
Publicado: (2021)

Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome
por: Hrenak, Jaroslav, et al.
Publicado: (2020)

New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
por: Paulis, Ludovit, et al.
Publicado: (2015)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System
por: Maris, Stephen A, et al.
Publicado: (2019)

Erratum for The renin‐angiotensin‐aldosterone system and its suppression
Publicado: (2019)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_isgqbj90b5g5ruamnn0pcnloph